Introduction
Moulds of the genus Aspergillus are opportunistic pathogens, especially in immunologically compromised patients. 1 Currently, amphotericin B is recommended as the drug of choice for the treatment of systemic infections. Itraconazole might be an alternative. 1 Most studies on invitro susceptibility have focused on Aspergillus fumigatus and Aspergillus flavus, the leading pathogens of the genus in humans. 2, 3, 4, 5 Technical procedures for susceptibility testing of moulds are currently not standardized and there was until now no established correlation between in-vitro results and in-vivo outcome. 6 Furthermore, the results of studies on susceptibility testing are difficult to compare since in most studies only clinical isolates were tested without using reference strains from culture collections. Only the parallel testing of a number of reference strains enables laboratories to standardize technical procedures and to evaluate new techniques. Therefore, susceptibility testing of 27 strains of five different Aspergillus spp. against amphotericin B and itraconazole was performed. Additionally, the widely used test media yeast nitrogen broth and RPMI-1640 were compared.
Materials and methods
Twenty-seven Aspergillus strains were purchased from three different sources: (i) Centralbureau voor Schimmelcultures (CBS, Baarn and Delft, The Netherlands), (ii) American Type Culture Collection (ATCC, Rockville, MD, USA), and (iii) the National Collection of Pathogenic Fungi (NCPF, Bristol, UK). Eleven strains were isolated from human infections, eight strains were isolated from animals, and eight strains were isolated from the environment (Table) . The strains were subcultured on Sabouraud-dextrose agar (Unipath, Basingstoke, UK) at 35°C for 3 days. Conidia, harvested by swabbing, were suspended in test media (see below).
Amphotericin B was purchased from Squibb-von Heyden (Munich, Germany) in a formulation with 49% deoxycholate. The powder was dissolved in distilled water to an amphotericin B concentration of 320 mg/L. A further dilution step was performed in test media to a concentration of 128 mg/L. Itraconazole (R 51211 AS) was purchased from Janssen Biotech NV (Olen, Belgium). Ten milligrams of the substance was dissolved in a mixture of 2 mL of 2 N HCl and 8 mL of dimethylsulphoxide (DMSO, Sigma-Aldrich Chemie, Deisenhofen, Germany). Ninety millilitres of distilled water was added, and 32 mL of the solution was made up to 100 mL with the appropriate test medium. This procedure resulted in an itraconazole concentration of 32 mg/L.
Each well of sterile 96-well microtitre plates was filled with 100 L of either YNB (yeast nitrogen broth, 6. with 0.165M 3-(N-morpholino)propanesulphonic acid (MOPS, Sigma)). One hundred microlitres of the stock solutions of the antimycotic agents was added and serial dilutions were performed. Thereafter, 100 L of the conidial suspensions ( 10 5 cfu/mL) was added to each of the wells. The concentrations of amphotericin B were in the range 0.03-32 mg/L, those of itraconazole 0.015-8 mg/L. One well remained without antimycotic agent, as a positive control. The plates were incubated at 35°C and the results were determined after 48 h by visual examination. Growth in each well was scored in comparison with that of the drug-free growth control and a numerical score (0-4) was given as recommended. 7 The MIC endpoint was defined as the drug concentration that was given a growth score of 1 ( 75% reduction of growth) in the case of itraconazole, and a score of 0 (optically clear) with amphotericin B. 7 All experiments were performed twice simultaneously and were repeated at least once to verify reproducibility.
A. fumigatus ATCC 90906 (kindly provided by Dr H. Dermoumi, Institut für Medizinische Mikrobiologie, Universität-GH Essen) with published MIC values of amphotericin B and itraconazole 2 was tested in parallel on each plate.
The results were interpreted as follows: a strain was designated as resistant when it showed an amphotericin B MIC of 1 mg/L and an itraconazole MIC of 1 mg/L. 
Results and discussion
To the author's knowledge, this is the first comparative study on susceptibility testing of a large number of culture collection strains of the genus Aspergillus using yeast nitrogen broth and RPMI-1640. Some findings appear to be important for standardizing susceptibility tests of moulds.
Firstly, when comparing the MIC values of amphotericin B and itraconazole in the two media (Table) , differences of no more than one dilution step were found in 21 out of 27 Aspergillus strains. In RPMI-1640, a trend towards lower MICs was seen in 19 strains. However, differences of two dilution steps in the six strains did not influence the interpretation (susceptible or resistant) of the results, indicating that both media are suitable for susceptibility testing of Aspergillus spp.
Secondly, all the strains were sensitive to itraconazole (MIC values 0.03-0.5 mg/L). These results are in agreement with the literature, 3, 5, 8, 9 although in two studies 4,10 strains of A. fumigatus were reported to be resistant to this agent. All the A. fumigatus and Aspergillus niger strains showed MIC values of amphotericin B in the range 0.125-0.5 mg/L, indicating susceptibility as described earlier. [2] [3] [4] [5] 8 However, a remarkable frequency of resistance to amphothericin B (MIC 2-6 mg/L) was found in A. flavus (five out of eight strains) and Aspergillus nidulans (four out of five strains). Although only two strains of Aspergillus terreus were examined, the results indicate that this species might be resistant to amphotericin B (MIC 1-2 mg/L). Similar results for this species have previously been found by other workers. 8 Thirdly, no differences in susceptibility were found between those strains isolated from humans and those isolated from animals and from the environment, indicating that susceptibility testing of moulds seems not to be useful for epidemiological studies.
It is concluded that susceptibility testing should be performed with each clinical isolate of the genus Aspergillus. Both yeast nitrogen broth and RPMI-1640 are useful for in-vitro testing. For the evaluation of newly developed techniques for susceptibility testing, the culture collection strains tested in this study can be used as reference strains.
